Becton Dickinson/BDX

$227.93

-0.38%
-
1D1W1MYTD1YMAX

About Becton Dickinson

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Ticker

BDX

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Thomas Polen

Employees

73,000

Headquarters

Franklin lakes, United States
Website
www.bd.com

Becton Dickinson Metrics

BasicAdvanced
$66B
Market cap
50.37
P/E ratio
$4.54
EPS
0.44
Beta
$3.72
Dividend rate
1.66%
Dividend yield
$66B
0.44302
$287.32
$228.09
1.4M
$3.72
1.411
0.971
62.366
70.227
79.03%
44.531
6.91%
2.54%
5.31%
2.94%
50.372
3.354
2.591
34.367
1.4%
1.63%
1.66%
4.82%
-13.64%
6.42%
80.44%
4.83%

What the Analysts think about Becton Dickinson

Analyst Ratings

Majority rating from 17 analysts.
Buy

Price Targets

Average projection from 14 analysts.
20.96% upside
High $315.00
Low $240.00
$227.93
Current price
$275.71
Average price target

Becton Dickinson Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.64% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$5B
7.2%
Net income
$537M
90.43%
Profit margin
10.64%
77.63%

Becton Dickinson Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 6.76%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$2.96
$3.42
$2.68
$3.17
-
Expected
$2.91
$3.43
$2.40
$2.97
$3.31
Surprise
1.59%
-0.16%
11.66%
6.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Becton Dickinson stock?

Becton Dickinson (BDX) has a market cap of $66B as of May 28, 2024.

What is the P/E ratio for Becton Dickinson stock?

The price to earnings (P/E) ratio for Becton Dickinson (BDX) stock is 50.37 as of May 28, 2024.

Does Becton Dickinson stock pay dividends?

Yes, the Becton Dickinson (BDX) stock pays dividends to shareholders. As of May 28, 2024, the dividend rate is $3.72 and the yield is 1.66%. Becton Dickinson has a payout ratio of 79.03% on a trailing twelve-month basis.

When is the next Becton Dickinson dividend payment date?

The next Becton Dickinson (BDX) dividend payment is scheduled for June 28, 2024.

What is the beta indicator for Becton Dickinson?

Becton Dickinson (BDX) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Becton Dickinson stock price target?

The target price for Becton Dickinson (BDX) stock is $275.71, which is 20.96% above the current price of $227.93. This is an average based on projections from 14 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Becton Dickinson stock

Buy or sell Becton Dickinson stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing